Enrique Reyes-Muñoz

Dr. Enrique Reyes-Muñoz

Gynecological and Perinatal Endocrinology, Instituto Nacional de Perinatología, Mexico City, Ciudad de México, Mexico
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in Reproduction
Verified
Journal Article
Closed access
PDF file
EVEDGAR RICARDO VAZQUEZ-MARTINEZ
EDGAR RICARDO VAZQUEZ-MARTINEZ
YGYadira Inés Gómez-Viais
Yadira Inés Gómez-Viais
EGElizabeth García-Gómez
Elizabeth García-Gómez
CRChristian Reyes-Mayoral
Christian Reyes-Mayoral
EREnrique Reyes-Muñoz
Enrique Reyes-Muñoz
MCMarco Cerbón
Marco Cerbón
Polycystic ovary syndrome (PCOS) is the leading endocrine and metabolic disorder in premenopausal women characterized by hyperandrogenism and abnormal development of ovarian follicles. To date, the PCOS etiology remains unclear and has been related to insulin resistance, obesity, type 2 diabetes mellitus, cardiovascular disease and infertility, among other morbidities. Substantial evidence illustrates the impact of genetic, intrauterine and environmental factors on the PCOS etiology. Lately, epigenetic factors have garnered considerable attention in the pathogenesis of PCOS considering that changes in the content of DNA methylation, histone acetylation and noncoding RNAs have been reported in various tissues of women with this disease. DNA methylation is changed in the peripheral and umbilical cord blood, as well as in ovarian and adipose tissue of women with PCOS, suggesting the involvement of this epigenetic modification in the pathogenesis of the disease. Perhaps, these defects in DNA methylation promote the deregulation of genes involved in inflammation, hormone synthesis and signaling and glucose and lipid metabolism. Research on the role of DNA methylation in the pathogenesis of PCOS is just beginning, and several issues await investigation. This review aims to provide an overview of current research focused on DNA methylation and PCOS, as well as discuss the perspectives regarding this topic.

BSBlanca Vianey Suarez-Rico
Blanca Vianey Suarez-Rico
GEGuadalupe Estrada-Gutierrez
Guadalupe Estrada-Gutierrez
MSMaribel Sánchez-Martínez
Maribel Sánchez-Martínez
OPOtilia Perichart
Otilia Perichart
CRCarolina Rodríguez-Hernández
Carolina Rodríguez-Hernández
EREnrique Reyes-Muñoz
Enrique Reyes-Muñoz
The COVID-19 lockdown represents a new challenge for mental health researchers and clinical practitioners. This cross-sectional study aimed to investigate the prevalence of depression, anxiety, and perceived stress in postpartum Mexican women. The study included 293, 4–12-week postpartum women over the age of 18. The Edinburgh Postpartum Depression Scale (EPDS), Trait-State Trait Anxiety Inventory (T-STAI), and Ten Perceived Stress Scale (PSS-10), which are all questionnaires validated for the Mexican population, were applied using a web-based online survey. Prevalence and 95% confidence intervals (CIs) were calculated. The mean ± standard deviation (SD) of the maternal age was 29.9 ± 6.3 years; the EPDS score: 11 ± 6, T-STAI score: 41.7 ± 12.3, and PSS-10 score: 17.1 ± 7. The prevalence (95% CI) of the postpartum depression symptoms was 39.2% (34–45%), trait anxiety symptoms were found among 46.1% (32–43%) of the participants, and moderate and high perceived stress were in 58% (52–64) and 10.9% (7.8–15) of the participants, respectively. The prevalence of depressive symptoms, generalized anxiety, and perceived stress was higher among postpartum Mexican women during the COVID-19 outbreak than before the lockdown. Our findings highlight the importance of monitoring perinatal mental health during pandemics and the need to design effective psychologic interventions for these patients.

Verified
Journal Article
Open access
PDF file
Johnatan TorresJohnatan Torres
Johnatan Torres
IMIrma Eloisa Monroy Muñoz
Irma Eloisa Monroy Muñoz
JPJavier Pérez-Durán
Javier Pérez-Durán
Juan Mario Solis ParedesJuan Mario Solis Paredes
Juan Mario Solis Paredes
Zaira Alexi Camacho-Martinez Camacho-MartinezZaira Alexi Camacho-Martinez Camacho-Martinez
Zaira Alexi Camacho-Martinez Camacho-Martinez
EREnrique Reyes-Muñoz
Enrique Reyes-Muñoz
Gestational diabetes (GD) is a metabolic disorder characterized by glucose intolerance during pregnancy, significantly impacting maternal and fetal health. Its global prevalence is approximately 14%, with risk factors including obesity, family history of diabetes, advanced maternal age, and ethnicity, which are linked to cellular and molecular disruptions in glucose regulation and insulin resistance. GD is associated with short- and long-term complications for both the mother and the newborn. For mothers, GD increases the risk of developing type 2 diabetes, cardiovascular diseases, and metabolic syndrome. In the offspring, exposure to GD in utero predisposes them to obesity, glucose intolerance, and metabolic disorders later in life. This review aims to elucidate the complex cellular and molecular mechanisms underlying GD to inform the development of effective therapeutic strategies. A systematic review was conducted using medical subject headings (MeSH) terms related to GD’s cellular and molecular pathophysiology. Inclusion criteria encompassed original studies, systematic reviews, and meta-analyses focusing on GD’s impact on maternal and fetal health, adhering to PRISMA guidelines. Data extraction captured study characteristics, maternal and fetal outcomes, key findings, and conclusions. GD disrupts insulin signaling pathways, leading to impaired glucose uptake and insulin resistance. Mitochondrial dysfunction reduces ATP production and increases reactive oxygen species, exacerbating oxidative stress. Hormonal influences, chronic inflammation, and dysregulation of the mammalian target of rapamycin (mTOR) pathway further impair insulin signaling. Gut microbiota alterations, gene expression, and epigenetic modifications play significant roles in GD. Ferroptosis and placental dysfunction primarily contribute to intrauterine growth restriction. Conversely, fetal macrosomia arises from maternal hyperglycemia and subsequent fetal hyperinsulinemia, resulting in excessive fetal growth. The chronic inflammatory state and oxidative stress associated with GD exacerbate these complications, creating a hostile intrauterine environment. GD’s complex pathophysiology involves multiple disruptions in insulin signaling, mitochondrial function, inflammation, and oxidative stress. Effective management requires early detection, preventive strategies, and international collaboration to standardize care and improve outcomes for mothers and babies.

11 October 2018 in Advances in Therapy
Verified
Journal Article
Open access
PDF file
EREnrique Reyes-Muñoz
Enrique Reyes-Muñoz
Thozhukat  Sathyapalan Thozhukat Sathyapalan
Thozhukat Sathyapalan
PRPaola Rossetti
Paola Rossetti
MSMohsin Shah
Mohsin Shah
MLMin Long
Min Long
SVSalvatore Giovanni Vitale
Salvatore Giovanni Vitale
Polycystic ovary syndrome (PCOS) affects 6–10% of women and could be considered one of the most common endocrine alterations in women of reproductive age. The syndrome is characterized by several hormonal and metabolic alterations, including insulin resistance and hyperandrogenism, which play a severe detrimental role in the patient’s fertility. We aimed to offer an overview about drug metabolism in the PCOS population. Nevertheless, we did not find any study that directly compared drug metabolism between PCOS and healthy women. We therefore decided to summarize briefly how hormonal and insulin sensitizer drugs act differently in healthy and PCOS women, who show altered steroidogenesis by theca cells and metabolic imbalance, focusing especially on assisted reproductive techniques. To date, data about drug metabolism in the PCOS population appears to be extremely limited. This important gap could have significant implications for therapeutic approaches and future perspectives: the dosage of drugs commonly used for the treatment of PCOS women should be tailored according to each patient’s characteristics; we should implement new clinical trials in order to identify the best pharmacologic strategy for PCOS patients undergoing in vitro fertilization (IVF); it would be advisable to create an international expert panel to investigate the drug metabolism in the PCOS population.

29 July 2017 in Pathogens and Disease
Verified
Journal Article
Closed access
PDF file
Moisés León-JuárezMoisés León-Juárez
Moisés León-Juárez
MMMacario Martínez–Castillo
Macario Martínez–Castillo
LGLuis Didier González-García
Luis Didier González-García
AHAddy Cecilia Helguera-Repetto
Addy Cecilia Helguera-Repetto
VZVerónica Zaga-Clavellina
Verónica Zaga-Clavellina
EREnrique Reyes-Muñoz
Enrique Reyes-Muñoz
The placenta is a highly specialized organ that is formed during human gestation for conferring protection and generating an optimal microenvironment to maintain the equilibrium between immunological and biochemical factors for fetal development. Diverse pathogens, including viruses, can infect several cellular components of the placenta, such as trophoblasts, syncytiotrophoblasts and other hematopoietic cells. Viral infections during pregnancy have been associated with fetal malformation and pregnancy complications such as preterm labor. In this minireview, we describe the most recent findings regarding virus–host interactions at the placental interface and investigate the mechanisms through which viruses may access trophoblasts and the pathogenic processes involved in viral dissemination at the maternal–fetal interface.

9 May 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
Salvatore Giovanni VitaleSalvatore Giovanni Vitale
Salvatore Giovanni Vitale
RWRafał Watrowski
Rafał Watrowski
Fabio BarraFabio Barra
Fabio Barra
Maurizio Nicola D'AlterioMaurizio Nicola D'Alterio
Maurizio Nicola D'Alterio
Jose CarugnoJose Carugno
Jose Carugno
Stefano AngioniStefano Angioni
Stefano Angioni
Abnormal uterine bleeding (AUB) is a frequent symptom in perimenopausal women. It is defined as uterine bleeding in which the duration, frequency, or amount of bleeding is considered excessive and negatively affects the woman’s quality of life (QoL) and psychological well-being. In cases of structural uterine pathology, hysterectomy (usually performed via a minimally invasive approach) offers definitive symptom relief and is associated with long-lasting improvement of QoL and sexuality. However, over the past 30 years, uterus-preserving treatments have been introduced as alternatives to hysterectomy. Hysteroscopic polypectomy, myomectomy, or endometrial resection/endometrial ablation are minimally invasive techniques that can be used as an alternative to hysterectomy to treat AUB due to benign conditions. Although associated with high patient satisfaction and short-term improvement in their QoL, hysteroscopic treatments do not eliminate the risk of AUB recurrence or the need for further intervention. Therefore, considering the impact of different treatment options on QoL and sexuality during preoperative shared decision making could help identify the most appropriate and personalized treatment options for perimenopausal women suffering from AUB.